Title

Second to fourth digit ratio and prostate cancer severity

Authors

Authors

M. Waters; C. M. Rebholz; B. Wood; A. Kuske; M. McIntyre;O. Sartor

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Prostate Cancer Prostatic Dis.

Keywords

digit ratio; 2D:4D; Gleason score; stage; FINGER-LENGTH PATTERNS; SEX; TESTOSTERONE; DIMORPHISM; OUTCOMES; Oncology; Urology & Nephrology

Abstract

BACKGROUND: The ratio of the second to the fourth digit (2D:4D ratio) is a sexually dimorphic trait established in utero that differs between ethnic groups. It is associated with prenatal androgen exposure, and studies have evaluated the ratio as a marker for certain traits and disease states known to be associated with higher levels of in utero androgens, such as prostate cancer. There are currently no screening tools that stratify men with prostate cancer according to the severity of their disease. This study aims to investigate the 2D:4D ratio as a potential marker for prostate cancer severity. Our hypothesis was that lower digit ratios, representing higher in utero androgen exposure, would be associated with more severe disease. METHODS: Measurements were taken of the second and fourth digits of the right hand of male patients diagnosed with prostate cancer. Gleason score, presence of metastasis, family history, age at diagnosis and race were recorded. The distribution of demographic and other patient characteristics were compared with digit ratios to determine relationships. RESULTS: African-American men with prostate cancer are 3.70 times more likely to have a low 2D:4D digit ratio than Caucasian men with prostate cancer (95% confidence interval: 1.98, 6.92; P < 00.0001). There were no statistically significant differences in the presence of metastasis, Gleason score, family history or age at diagnosis by digit ratio. CONCLUSION: 2D:4D ratio shows strong differences between African-Americans and Caucasians; however, it does not correlate with disease severity in men already diagnosed with prostate cancer. Although this is a small population sample with possible confounding factors, it does not provide evidence to support the hypothesis that prenatal androgens affect prostate cancer grade or progression. Prostate Cancer and Prostatic Disease (2013) 16, 106-109; doi:10.1038/pcan.2012.46; published online 13 November 2012

Journal Title

Prostate Cancer and Prostatic Diseases

Volume

16

Issue/Number

1

Publication Date

1-1-2013

Document Type

Article

Language

English

First Page

106

Last Page

109

WOS Identifier

WOS:000314866700018

ISSN

1365-7852

Share

COinS